Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
6.79
+0.04 (0.59%)
Oct 7, 2026, 11:04 AM EDT - Market open
Cartesian Therapeutics Earnings Call Transcripts
Fiscal Year 2026
-
The meeting confirmed a quorum, elected three directors for terms expiring in 2029, and saw overwhelming approval for executive compensation and auditor ratification, each with 99% support. No questions were raised by stockholders during the Q&A.